Abstract
Coronary heart disease (CHD) is among one of the major causes of deaths in Mauritius. It is important to screen biochemical markers, amongst other clinical and para-clinical tests, in view of the prevention of the disease. The study consisted of screening a random sample of 300 employees for total cholesterol above the desirable range (>5.17 mmol/l). A second fasting blood test was performed in those who had high total cholesterol. The lipid profile was performed using commercially available kits. The Total Cholesterol to High Density Lipoprotein Cholesterol ratio was calculated for identification of those at risk of CHD.
The findings showed an important prevalence of blood lipid abnormalities in the studied population, thus highlighting the need for screening for abnormal levels of these biochemical markers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (2004) Global burden of coronary heart disease. In: Mackay J, Mensah G (eds) The atlas of heart disease and stroke, Part 3: the burden. World Health Organization, Geneva. http://www.who.int/cardiovascular_diseases/resources/atlas/en/. Accessed 8 Sept 2010
World Health Organization (2005) Preventing chronic diseases: a vital investment. World Health Organization, Geneva. http://www.who.int/. Accessed 8 Sept 2010
Brewer HB (2004) A new dawn in the treatment of Dyslipidaemia: cardiovascular risk reduction through emerging science and proven clinical results. Am Heart J 148:S1–S2
Gupta R, Gupta HP, Kumar N, Joshi AK, Gupta VP (1994) Lipoprotein lipids and the prevalence of hyperlipidaemia in rural India. J Cardiovasc Risk 1:179–184
Rafiei M, Boshtam M, Sarraf-Zadegan N (1999) Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994. East Mediterr Health J 5:766–777
Foucan L, Kangambega P, Koumavi Ekouevi D, Rozet JE, Bangou-Brédent J (2000) Lipid profile in an adult population in Guadeloupe. Diabetes Metab 26:473–480
Yarzebski J, Spencer F, Goldberg RJ, Lessard D, Gore JM (2001) Temporal trends (1986–1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction. Arch Intern Med 161:1521–1528
Wang TD, Chen WJ, Chien KL, Su SS, Hsu HC, Chen MF, Liau CS, Lee YT (2001) Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a chinese population. Am J Cardiol 88:737–743
American Association of Clinical Endocrinologist (AACE) (2002) AACE lipid guidelines. Endocr Pract 6:4–52
Eghan BA Jr, Acheampong JW (2003) Dyslipidaemia in outpatients at General Hospital in Kumasi, Ghana: cross-sectional study. Croat Med J 44:576–578
National Cholesterol Education Program Expert Panel (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adults Treatment Panel III). J Am Med Assoc 285:2486–2497
Rifai N, Bachorik PS, Albers JJ (1999) Lipids, lipoproteins & apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd edn. Saunders, Philadelphia, pp 809–861
World Health Organization (2010) Health systems financing: the path to universal coverage. The world health report 2010. World Health Organization, Geneva. http://www.who.int/whr/2010/en/index.html. Accessed 8 Sept 2010
Ministry of Health and Quality of Life, Republic of Mauritius (2009) The trends in diabetes and cardiovascular disease risk in Mauritius. Mauritius non communicable diseases survey report
United States Preventive Services Task Force (2008) Screening for lipid disorders in adults: recommendation statement. http://www.uspreventiveservicestaskforce.org/uspstf08/lipid/lipidrs.htm. Accessed 8 Sept 2010
United States Preventive Services Task Force (2002) Screening for lipid disorders in adults: recommendations and rationale. Internet J Intern Med 3(2). http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijim/vol3n2/lipid.xml. Accessed 8 Sept 2010
Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915–922
Cheng J, Zhao D, Zeng Z, Critchley JA, Liu J, Wang W, Sun J, Capewell S (2009) The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing (1999–2010). BMC Public Health 9:30
Gupta R, Kaul V, Bhagat N, Agrawal M, Gupta VP, Misra A, Vikram NK (2008) Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4. Indian Heart J 156:112–119
Ghandehari H, Kamal-Bahl S, Wong ND (2008) Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004. Am Heart J 156:112–119
Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Despres JP (2001) Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. Arch Intern Med 161:2685–2692
Bersot TP, Pépin GM, Mahley RW (2003) Risk determination in populations characterised by low levels of high-density lipoprotein cholesterol. Am Heart J 146:1052–1060
Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57
Centers for Disease Control. Heart Disease (On line). Available at http://www.cdc.gov/Features/WorldHeartDay/. Accessed 30 Sept 2010
Acknowledgements
The authors are thankful to the staff of the Department of Medicine, University of Mauritius for technical support provided.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Albana, D., Sun, M.C. (2012). Screening Biochemical Markers for the Prevention of Coronary Heart Disease. In: Gupta Bhowon, M., Jhaumeer-Laulloo, S., Li Kam Wah, H., Ramasami, P. (eds) Chemistry for Sustainable Development. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8650-1_31
Download citation
DOI: https://doi.org/10.1007/978-90-481-8650-1_31
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8649-5
Online ISBN: 978-90-481-8650-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)